ANG Lifesciences Intrinsic Value
ANG Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹58.35 | ₹52.52 - ₹64.19 | +150.0% | Book Value/Share: ₹49.23, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹46.68 | ₹42.01 - ₹51.35 | +100.0% | Revenue/Share: ₹80.00, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹58.35 | ₹46.68 - ₹70.02 | +150.0% | CF Growth: 4.0%, Discount: 15% |
Want to compare with current market value? Check ANG share price latest .
Valuation Comparison Chart
ANG Intrinsic Value Analysis
What is the intrinsic value of ANG?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of ANG Lifesciences (ANG) is ₹58.35 (median value). With the current market price of ₹23.34, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹46.68 to ₹58.35, indicating ₹46.68 - ₹58.35.
Is ANG undervalued or overvalued?
Based on our multi-method analysis, ANG Lifesciences (ANG) appears to be trading below calculated value by approximately 150.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.32 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 3.59 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -18.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 0.45x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for ANG Lifesciences
Additional stock information and data for ANG
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-10 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹26 Cr | ₹22 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹25 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |